A Phase I Study of KLA318-2 Nanocrystal Injection

Clinical trial NCT07171034 · RECRUITING

Trial details

NCT number: NCT07171034
Sponsor: Hunan Kelun Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2025-09-01
Primary completion: 2026-05-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.